Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $1.48 0.1500 +11.28%
SRNE $20.41 1.2100 +6.30%
BPTH $1.25 0.0600 +5.04%
OMED $21.61 0.9000 +4.35%
GTXI $1.11 0.0400 +3.74%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.08 -0.0200 -20.00%
CYTK $6.09 -0.9700 -13.74%
ONCY $0.57 -0.0390 -6.39%
ALPMY $14.88 -0.9000 -5.70%
ATRA $55.59 -3.2400 -5.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

CT Scans Can Damage Patients' DNA, Study Finds

(CBS News/HealthDay News) July 22, 2015 - Cellular damage occurs when people undergo CT scans, but whether or not this causes cancer or any other health problems is unclear, a new study finds.
read article 



Moffitt Cancer Center Researchers Develop First Genetic Test to Predict Tumor Sensitivity to Radiation Therapy

(Moffitt) July 22, 2015 - Moffitt researchers have discovered that colon cancer metastases have varying sensitivity to radiation therapy based on their anatomic location.
read press release 



Lymph Node Radiation May Halt Breast Cancer Recurrences

(Cleveland Clinic/HealthHub) July 22, 2015 - Two new studies show promising results for the use of radiation therapy to prevent breast cancer from coming back.
read article 



Amgen Submits Supplemental New Drug Application For Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma

(Amgen) July 23, 2015 - Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Kyprolis® (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.
read corporate press release 



The High Cost of Cancer Care: Your Money or Your Life?

(Newsweek) July 23, 2015 - New cancer drugs can extend life for days, months, even years. But they can also push you and your family into bankruptcy.
read article (free registration required) 



Top Oncologists Push Back on ‘Outrageous’ Costs of Cancer Drugs’

(KHN Morning Briefing) July 23, 2015 - More than 110 doctors from cancer centers around the country called on drug makers to justify their soaring prices and for the government to put regulatory curbs in place. They noted that every new drug approved by the Food and Drug Administration in 2014 was priced at more than $120,000 per year.
read article 



Leading Experts Prescribe How to Make Cancer Drugs More Affordable

(Mayo Clinic) July 22, 2015 - A group of 118 of the nation's leading cancer experts have drafted a prescription for reducing the high cost of cancer drugs and voiced support for a patient-based grassroots movement demanding action on the issue.
read press release 



European Medicines Agency Validates Two Parallel Type II Variation Applications to Extend the Opdivo (nivolumab) Indication in Europe

(MarketWatch) July 23, 2015 - Bristol-Myers Squibb Company today announced that the European Medicines Agency (EMA) has validated two of the company’s type II variation applications, which seek to extend the current indication for its Immuno-Oncology agent, Opdivo.
read article 



Merck & Co's Keytruda Approved In EU for Melanoma

(PharmaTimes [UK]) July 22, 2015 - Merck & Co’s anti-PD-1 therapy Keytruda has been approved in Europe for the treatment of advanced skin cancer.
read article 



AZ' Selumetinib Fails In Late-Stage Eye Cancer Trial

(PharmaTimes [UK]) July 22, 2015 - AstraZeneca has been dealt a blow on the failure of its MEK inhibitor selumetinib to show a significant progression-free survival benefit in patients with a rare eye cancer.
read article 



Many Doctors Use False Addresses In Medicare, GAO Finds

(KHN Morning Briefing) July 22, 2015 - In a new report, federal investigators found that some screening problems persist among the 1.8 million providers enrolled in the program. For instance, about 23,400 addresses might be invalid.
read article 



Mixed Result On Biogen Alzheimer's Drug As 6Mg Dose Falls Short

(Reuters) July 22, 2015 - A 6 mg dose of Biogen's experimental Alzheimer's disease drug significantly reduced beta amyloid plaque in the brain but failed to significantly slow mental decline, potentially tempering great enthusiasm that greeted data on two other doses of the treatment earlier this year.
read article 



Lilly Says Drug Slows Alzheimer's In Patients With Mild Disease

(Reuters) July 22, 2015 - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday.
read article 



Pfizer to Consolidate Its Research Labs, Create Unified Campus Outside Kendall Square

(Boston Globe) July 22, 2015 - The drug giant Pfizer Inc. will consolidate operations at several Cambridge locations and move hundreds of employees into a huge, unified research campus outside of Kendall Square.
read article (free registration required) 



Pfizer Is Expanding Its Vaccine Portfolio, Developing Others

(ABC News/Associated Press) July 21, 2015 - Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems, company officials said Tuesday during a media briefing.
read article 



Cellphone Ordinance Puts Berkeley at Forefront of Radiation Debate

(New York Times) July 21, 2015 - A city measure requiring retailers to warn cellphone customers about radiation exposure is on hold pending a lawsuit from the wireless industry.
read article 



Leukemia "Charity" Sued For Alleged False Claims

(USA Today) July 21, 2015 - The National Children's Leukemia Foundation's Facebook page described the Brooklyn, N.Y. organization as one of the leading groups "in the battle against leukemia and cancer in children and adults."
read article 



MD Anderson Named As One Of Two Genome Characterization Centers

(MD Anderson) July 22, 2015 - Named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer Institute (NCI).
read press release 



CompanionDx® Selects N-of-One’s Cost-effective, High-quality Clinical Interpretation for Targeted Next-generation Sequencing Tests

(Yahoo! Finance) July 22, 2015 - N-of-One providing cost-effective clinical interpretation for focused and comprehensive gene panels.
read article 



NeoGenomics Expands Multimodality Cancer Profile Testing

(MarketWatch) July 22, 2015 - NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its comprehensive multimodality NeoTYPE™ tumor-type specific cancer profiling tests to include new profiles for head and neck tumors, pancreatic cancer, liver cancer, sarcoma, and for cancers of unknown primary ("CUP").
read article 



Ablynx Significantly Expands Its Immuno-Oncology Collaboration With Merck & Co., Inc.

(TheStreet) July 22, 2015 - Ablynx today announced an expansion of its immuno-oncology collaboration with a subsidiary of Merck & Co., Inc., [known as MSD outside the United States and Canada], to address an increased number of immune checkpoint modulator targets.
read article 



Medicare Releases Proposed Payment Rates and Associated Policies for Physicians in 2016

(ASH) July 21, 2015 - On July 8, 2015, the Centers for Medicare and Medicaid Services (CMS) released its proposed rule governing payments for physician services and other associated policies covering the calendar year of 2016.
read article 



Amgen Distributes Important Safety Updates on Blincyto®

(ASCO in Action) July 21, 2015 - The Food and Drug Administration (FDA) has required Amgen to distribute a safety update on Blincyto® (blinatumomab) to professional societies as part of its REMS (Risk Evaluation and Mitigation Strategy) program.
read article 



CMS Finalizes Decision to Cover HPV Testing for Cervical Cancer

(Doctors Lounge/HealthDay News) July 21, 2015 — The Centers for Medicare & Medicaid Services (CMS) has finalized the decision to cover human papillomavirus (HPV) testing once every five years in conjunction with a Pap smear test for asymptomatic Medicare beneficiaries aged 30 to 65 years, according to a report published by the American Academy of Family Physicians (AAFP).
read article 



Op-Ed: When Screening Is Bad For A Woman's Health

(Los Angeles Times) July 19, 2015 - If you haven't gotten this message already, you should heed it now: The benefits of screening for breast cancer are limited. We should be doing fewer screening mammograms, not more.
read article (free registration required)